|
Market Closed -
Euronext Paris
11:55:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.3825 EUR | -0.13% |
|
-0.65% | +28.36% |
| 08-10 | Nicox Sa and Ocumension Therapeutics Submit Ncx 470 New Drug Application in China | CI |
| 08-10 | Nicox Partner Files China Drug Application for NCX 470 Eye Drop | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NICOX SA | Specialty & Advanced Pharmaceuticals | -0.13% | -0.65% | +28.36% | +4.22% | -88.23% | 39.35M |  |  | |
- Stock Market
- Stocks
- ALCOX Stock
- Charts Nicox SA
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
